Search

everythinglearnresearchcommunity

for

Search:↓

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Chlorinated compounds like TCDD can cause skin issues and chloracne by affecting cell behavior.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

TQC shows promise for better hair regrowth in treating hair loss.

TCM is an effective and safe treatment for primary cicatricial alopecias.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tacalcitol ointment effectively improves bilateral nevus comedonicus.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

MPA increases cancer spread by boosting Eph A2 activity.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Tofacitinib treatment is used for teenagers with alopecia areata.

Bacillus sp. TC5 products help hair regrowth and improve skin drug absorption.